We use cookies to understand how you use our site and to improve the overall user experience. This includes personalizing content and advertising. Read our Privacy Policy
Elsiglutide is a pharmaceutical peptide used in the biomedical industry to manage type 2 diabetes and obesity. It acts as a glucagon-like peptide-1 (GLP-1) receptor agonist, helping to regulate blood sugar levels and promote weight loss. Elsiglutide’s mechanism of action includes increasing insulin release, reducing glucagon secretion, and slowing gastric emptying, resulting in improved glycemic control and decreased appetite.
Peptide Library Construction and Screening
Powerful screening tools in biological and chemical research
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at info@creative-peptides.com. We will endeavor to provide highly satisfying products and services.
USA
Address: SUITE 115, 17 Ramsey Road, Shirley, NY 11967, USA
Tel: 1-631-624-4882
Fax: 1-631-614-7828
Email: info@creative-peptides.com
Germany
Address: Industriepark Höchst, Gebäude G830
65929 Frankfurt am Main
Email: info@creative-peptides.com